Results 71 to 80 of about 3,735,339 (297)

Epidemiological study of Acinetobacter baumannii nosocomial infections [PDF]

open access: yes, 2021
Universitatea de Stat de Medicină și Farmacie „NicolaeTestemițanu”, Republica MoldovaIntroduction. Acinetobacter baumannii is a pathogen and a major cause of nosocomial infections in the current healthcare system worldwide due to its high resistance to ...
Prisacari, Viorel, Andronachi, Nicoleta
core  

Acinetobacter spp. in food and drinking water – a review

open access: yes, 2021
Acinetobacter spp. has emerged as a pathogen of major public health concern due to their increased resistance to antibiotics and their association with a wide range of nosocomial infections, community-acquired infections and war and natural disaster ...
Silva, Joana   +2 more
core   +1 more source

Comparing the Outcomes of Cefoperazone/Sulbactam-Based and Non-Cefoperazone/Sulbactam-Based Therapeutic Regimens in Patients with Multiresistant Acinetobacter baumannii Infections—A Meta-Analysis

open access: yesAntibiotics
The addition of sulbactam restores the complete range of cefoperazone activity against bacteria and extends its spectrum of action to include the Acinetobacter species.
Chienhsiu Huang, Lichen Lin, Sufang Kuo
doaj   +1 more source

Acinetobacter baumannii in ICU patients: A prospective study highlighting their incidence, antibiotic sensitivity pattern and impact on ICU stay and mortality

open access: yesEgyptian Journal of Chest Disease and Tuberculosis, 2017
Background: Acinetobacter baumannii (A. baumannii) was considered as a leading cause of nosocomial respiratory infection and bacteremia in many hospitals all over the world. However, there was still a debates whether colonization and/ or infection with A.
Ashraf E. Sileem   +2 more
doaj   +1 more source

Emergence of Highly Multidrug-Resistant Bacteria Isolated from Patients with Infections Admitted to Public Hospitals in Southwest Iran

open access: yesInterdisciplinary Perspectives on Infectious Diseases, 2021
Background. The emergence of multidrug-resistant (MDR) microorganisms causing infections is increasing worldwide and becoming more serious in developing countries. Among those, Acinetobacter species are becoming prominent. Objectives.
Sepide Namdari   +4 more
doaj   +1 more source

DNA Nanoarray for Multiplexed RNA Detection With Single‐Molecule Readout

open access: yesAdvanced Science, EarlyView.
A carrier‐based DNA nanoarray integrates programmable nucleic acid hybridization with solid‐state nanopore readout for direct RNA detection at single‐molecule resolution. A ternary encoding system enables 27 carriers with 81 addressable sensing sites, allowing the simultaneous identification of targets spanning a wide size range, from short microRNAs ...
Yunxuan Li   +12 more
wiley   +1 more source

Multi‐Targeting Carnosic Acid Kills Drug‐Resistant Helicobacter pylori With Narrow‐Spectrum Activity

open access: yesAdvanced Science, EarlyView.
Carnosic acid selectively eradicates drug‐resistant Helicobacter pylori through a multi‐targeted mechanism involving urease inhibition, membrane disruption, and biofilm eradication. It exhibits no detectable resistance, potent in vivo efficacy, and minimal impact on gut microbiota, positioning it as a promising narrow‐spectrum lead compound against ...
Yuefan Bai   +7 more
wiley   +1 more source

Acinetobacter in Veterinary Medicine with emphasis on A. baumannii [PDF]

open access: yes, 2019
Acinetobacter spp. are aerobic, rod-shaped Gram-negative bacteria belonging to the Moraxellaceae family of the class Gammaproteobacteria and are considered ubiquitous organisms.
Graubner, Claudia   +4 more
core   +1 more source

Update on the Epidemiology, Treatment, and Outcomes of Carbapenem-resistant Acinetobacter infections

open access: yesChonnam medical journal, 2014
Carbapenem-resistant Acinetobacter species are increasingly recognized as major nosocomial pathogens, especially in patients with critical illnesses or in intensive care.
U. Kim   +5 more
semanticscholar   +1 more source

Antimicrobial and Anti-Biofilm Activity of Polymyxin E Alone and in Combination with Probiotic Strains of Bacillus subtilis KATMIRA1933 and Bacillus amyloliquefaciens B-1895 against Clinical Isolates of Selected Acinetobacter spp.: A Preliminary Study

open access: yesPathogens, 2021
Acinetobacter spp., the nosocomial pathogen, forms strong biofilms and is resistant to numerous antibiotics, causing persistent infections. This study investigates the antibacterial and anti-biofilm activity of polymyxin E alone and in combination with ...
Munaf AL-Dulaimi   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy